Processa Pharmaceuticals

Processa Pharmaceuticals (Nasdaq: PCSA) is a clinical stage drug development company with a pipeline of compounds including next generation chemotherapy. The company is seeking partners for non-core assets including PCS499, an advanced clinical-stage compound for rare nephropathies.

Address

Hanover
Maryland
United States
Loading